These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

113 related items for PubMed ID: 7860046

  • 1. p53 quantitative immunocytochemical analysis in breast carcinomas.
    Charpin C, DeVictor B, Andrac L, Amabile J, Bergeret D, LaVaut MN, Allasia C, Piana L.
    Hum Pathol; 1995 Feb; 26(2):159-66. PubMed ID: 7860046
    [Abstract] [Full Text] [Related]

  • 2. Cathepsin D immunocytochemical assays in breast carcinomas: image analysis and correlation to prognostic factors.
    Charpin C, Devictor B, Bonnier P, Andrac L, Lavaut MN, Allasia C, Piana L.
    J Pathol; 1993 Aug; 170(4):463-70. PubMed ID: 8410496
    [Abstract] [Full Text] [Related]

  • 3. CD31 quantitative immunocytochemical assays in breast carcinomas. Correlation with current prognostic factors.
    Charpin C, Devictor B, Bergeret D, Andrac L, Boulat J, Horschowski N, Lavaut MN, Piana L.
    Am J Clin Pathol; 1995 Apr; 103(4):443-8. PubMed ID: 7726141
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Relationship between AgNOR proteins, Ki-67 antigen, p53 immunophenotype and differentiation markers in archival breast carcinomas.
    Bànkfalvi A, Schmitz K, Mock T, Kemper M, Cubick C, Böcker W.
    Anal Cell Pathol; 1998 Apr; 17(4):231-42. PubMed ID: 10391375
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Automated and quantitative immunocytochemical assays of Nm23/NDPK protein in breast carcinomas.
    Charpin C, Bouvier C, Garcia S, Martini F, Andrac L, Lavaut MN, Allasia C.
    Int J Cancer; 1997 Aug 22; 74(4):416-20. PubMed ID: 9291431
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Quantitative analysis of p185(HER-2/neu) protein in breast cancer and its association with other prognostic factors.
    Valerón PF, Chirino R, Vega V, Falcón O, Rivero JF, Torres S, León L, Fernández L, Pestano J, Díaz-Chico B, Díaz-Chico JC.
    Int J Cancer; 1997 Apr 22; 74(2):175-9. PubMed ID: 9133451
    [Abstract] [Full Text] [Related]

  • 12. p53 and c-erbB-2 protein expression in breast carcinomas. An immunohistochemical study including correlations with receptor status, proliferation markers, and clinical stage in human breast cancer.
    Barbareschi M, Leonardi E, Mauri FA, Serio G, Dalla Palma P.
    Am J Clin Pathol; 1992 Oct 22; 98(4):408-18. PubMed ID: 1357956
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Mutant p53 expression and DNA analysis in human breast cancer comparison with conventional clinicopathological parameters.
    Rosanelli GP, Steindorfer P, Wirnsberger GH, Klimpfinger M, Ratschek M, Puerstner P, Auner H, Berhold A.
    Anticancer Res; 1995 Oct 22; 15(2):581-6. PubMed ID: 7763041
    [Abstract] [Full Text] [Related]

  • 16. p53 associated with cathepsin D in primary breast cancer.
    Marsigliante S, Leo G, Mottaghi A, Biscozzo L, Greco S, Storelli C.
    Int J Clin Lab Res; 1993 Oct 22; 23(2):102-8. PubMed ID: 8518412
    [Abstract] [Full Text] [Related]

  • 17. Multiparametric study (SAMBA 200) of estrogen receptor immunocytochemical assay in 400 human breast carcinomas: analysis of estrogen receptor distribution heterogeneity in tissues and correlations with dextran coated charcoal assays and morphological data.
    Charpin C, Martin PM, De Victor B, Lavaut MN, Habib MC, Andrac L, Toga M.
    Cancer Res; 1988 Mar 15; 48(6):1578-86. PubMed ID: 2449956
    [Abstract] [Full Text] [Related]

  • 18. Immunofluorometric analysis of p53 protein and prostate-specific antigen in breast tumours and their association with other prognostic indicators.
    Levesque MA, Clark GM, Yu H, Diamandis EP.
    Br J Cancer; 1995 Sep 15; 72(3):720-7. PubMed ID: 7545416
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.